MyJournals Home  

RSS Feeds[Correspondence] Teriparatide vs risedronate for osteoporosis (Lancet)

 
 

13 may 2018 00:00:19

 
[Correspondence] Teriparatide vs risedronate for osteoporosis (Lancet)
 




David L Kendler and colleagues (Jan 20, p 230)1 compared the anti-fracture efficacy of subcutaneous teriparatide injections with that of oral risedronate in patients with severe osteoporosis, and indicated that the risk of new vertebral and clinical fractures is significantly lower in patients receiving teriparatide than in those receiving risedronate. Nevertheless, it seems to me that a comparison between a parenteral and an oral anti-osteoporosis drug might be of relatively minor clinical significance.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
42 viewsCategory: General
 
[Correspondence] Drawing conclusions from the VIVA trial - Authors` reply (Lancet)
[Correspondence] Teriparatide vs risedronate for osteoporosis - Authors` reply (Lancet)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

General

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn